Premium
Assessment of whole blood coagulation with a microfluidic dielectric sensor
Author(s) -
Maji D.,
De La Fuente M.,
Kucukal E.,
Sekhon U. D. S.,
Schmaier A. H.,
Sen Gupta A.,
Gurkan U. A.,
Nieman M. T.,
Stavrou E. X.,
Mohseni P.,
Suster M. A.
Publication year - 2018
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/jth.14244
Subject(s) - coagulation , hemostasis , platelet , whole blood , biomedical engineering , coagulation testing , thromboelastography , materials science , permittivity , medicine , dielectric , optoelectronics , immunology
Essentials ClotChip is a novel microsensor for comprehensive assessment of ex vivo hemostasis. Clinical samples show high sensitivity to detecting the entire hemostatic process. ClotChip readout exhibits distinct information on coagulation factor and platelet abnormalities. ClotChip has potential as a point‐of‐care platform for comprehensive hemostatic analysis.Summary Background Rapid point‐of‐care ( POC ) assessment of hemostasis is clinically important in patients with a variety of coagulation factor and platelet defects who have bleeding disorders. Objective To evaluate a novel dielectric microsensor, termed ClotChip, which is based on the electrical technique of dielectric spectroscopy for rapid, comprehensive assessment of whole blood coagulation. Methods The ClotChip is a three‐dimensional, parallel‐plate, capacitive sensor integrated into a single‐use microfluidic channel with miniscule sample volume (< 10 μL). The ClotChip readout is defined as the temporal variation in the real part of dielectric permittivity of whole blood at 1 MH z. Results The ClotChip readout exhibits two distinct parameters, namely, the time to reach a permittivity peak ( T peak ) and the maximum change in permittivity after the peak (Δε r,max ), which are, respectively, sensitive towards detecting non‐cellular (i.e. coagulation factor) and cellular (i.e. platelet) abnormalities in the hemostatic process. We evaluated the performance of ClotChip using clinical blood samples from 15 healthy volunteers and 12 patients suffering from coagulation defects. The ClotChip T peak parameter exhibited superior sensitivity at distinguishing coagulation disorders as compared with conventional screening coagulation tests. Moreover, the ClotChip Δε r,max parameter detected platelet function inhibition induced by aspirin and exhibited strong positive correlation with light transmission aggregometry. Conclusions This study demonstrates that ClotChip assesses multiple aspects of the hemostatic process in whole blood on a single disposable cartridge, highlighting its potential as a POC platform for rapid, comprehensive hemostatic analysis.